Therefore, this study aims to explore the activation of MYC target genes across various stages of CLL—including diagnosis, progression, relapse, and RT and various disease subgroups (e.g., unmutated IGHV-CLL cases (U-CLLs), genetic alterations). Here, MYC is linked to B-cell chronic lymphocytic leukemia.